Solco Biomedical Co (XKRX:043100) Total Liabilities : ₩38,758 Mil (As of Mar. 2024)

View and export this data going back to 2000. Start your Free Trial

What is Solco Biomedical Co Total Liabilities?

Solco Biomedical Co's Total Liabilities for the quarter that ended in Mar. 2024 was ₩38,758 Mil.

Solco Biomedical Co's quarterly Total Liabilities increased from Sep. 2023 (₩29,041.35 Mil) to Dec. 2023 (₩31,697.53 Mil) and increased from Dec. 2023 (₩31,697.53 Mil) to Mar. 2024 (₩38,757.57 Mil).

Solco Biomedical Co's annual Total Liabilities increased from Dec. 2021 (₩24,016.48 Mil) to Dec. 2022 (₩24,419.62 Mil) and increased from Dec. 2022 (₩24,419.62 Mil) to Dec. 2023 (₩31,697.53 Mil).

Solco Biomedical Co Total Liabilities Historical Data

The historical data trend for Solco Biomedical Co's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Solco Biomedical Co Total Liabilities Chart

Solco Biomedical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

23,284.07

22,405.44

24,016.48

24,419.62

31,697.53

Solco Biomedical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Liabilities	Get a 7-Day Free Trial															26,705.00	26,288.72	29,041.35	31,697.53	38,757.57

Solco Biomedical Co Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Solco Biomedical Co's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	26042.844	+	(4343.855	+	794.043
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	516.791)
	=	31,698

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	50676.951	-	18979.419
	=	31,698

Solco Biomedical Co's Total Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	26959.449	+	(8190.903	+	3338.004
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	269.217)
	=	38,758

Total Liabilities	=	Total Assets (Q: Mar. 2024 )	-	Total Equity (Q: Mar. 2024 )
	=	58289.892	-	19532.319
	=	38,758

Solco Biomedical Co Total Liabilities Related Terms

Thank you for viewing the detailed overview of Solco Biomedical Co's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Solco Biomedical Co (XKRX:043100) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Solco Biomedical Co Ltd (XKRX:043100) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

34-6 Keumam-ri, Seotan-myeon, Gyeonggi-do, Pyeongtaek, KOR, 451-852

Website

http://www.solco.co.kr

Solco Biomedical Co Ltd operates in the medical devices industry in South Korea. The products offered by the company include dressing and tissue forceps, scissors, needle holders, intestinal forceps, self-retaining retractors, hooks, and knife handles.

Solco Biomedical Co (XKRX:043100) Headlines

No Headlines